Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer
| Autor: | Schneider, Bryan J., Kalemkerian, Gregory P., Gadgeel, Shirish M., Valdivieso, Manuel, Hackstock, Deborah M., Chen, Wei, Heilbrun, Lance K., Ruckdeschel, John C., Wozniak, Antoinette J. |
|---|---|
| Zdroj: | In Clinical Lung Cancer May 2017 18(3):299-302 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect